Clinical Research Directory
Browse clinical research sites, groups, and studies.
LAG3 Expression in Triple Negative Breast Cancer
Sponsor: Samsung Medical Center
Summary
This study is the experimental study for relationship between LAG-3 expression / immue checkpoint protein expression and neoadjuvant chemotherapy plus immune checkpoint inhibitor in triple negative breast cancer.
Official title: The Evaluation the Relationship Between LAG-3 Expression / Immune Checkpoint Protein Expression and Neoadjuvant Chemotherapy Plus Immune Checkpoint Inhibitor in Triple Negative Breast Cancer
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
128
Start Date
2022-11-18
Completion Date
2027-12-31
Last Updated
2024-02-14
Healthy Volunteers
Yes
Interventions
LAG-3 expression / immune checkpoint protein expression
Evaluate the tissue and blood before and after chemotherapy
Locations (1)
Ji-Yeon Kim
Seoul, South Korea